E
CardioComm Solutions, Inc.
EKG.V
TSX
E
Sell
6/13/2024Downgrade
CardioComm Solutions, Inc. (EKG.V) was downgraded to E+ from D- on 6/13/2024 due to a large decline in the efficiency index.
CardioComm Solutions, Inc. (EKG.V) was downgraded to E+ from D- on 6/13/2024 due to a large decline in the efficiency index.
D
Sell
6/7/2024Downgrade
CardioComm Solutions, Inc. (EKG.V) was downgraded to D- from D on 6/7/2024 due to a decline in the volatility index.
CardioComm Solutions, Inc. (EKG.V) was downgraded to D- from D on 6/7/2024 due to a decline in the volatility index.
D
Sell
5/22/2024Upgraded
CardioComm Solutions, Inc. (EKG.V) was upgraded to D from D- on 5/22/2024 due to a noticeable increase in the total return index, volatility index and efficiency index.
CardioComm Solutions, Inc. (EKG.V) was upgraded to D from D- on 5/22/2024 due to a noticeable increase in the total return index, volatility index and efficiency index.
D
Sell
9/7/2023Downgrade
CardioComm Solutions, Inc. (EKG.V) was downgraded to D- from D on 9/7/2023 due to a noticeable decline in the growth index and efficiency index. Earnings per share declined from $0.0001 to $0, net income declined 77.78% from $11.7 to $2.6, and total revenue declined 27.97% from $193.8 to $139.6.
CardioComm Solutions, Inc. (EKG.V) was downgraded to D- from D on 9/7/2023 due to a noticeable decline in the growth index and efficiency index. Earnings per share declined from $0.0001 to $0, net income declined 77.78% from $11.7 to $2.6, and total revenue declined 27.97% from $193.8 to $139.6.
D
Sell
8/23/2023Upgraded
CardioComm Solutions, Inc. (EKG.V) was upgraded to D from D- on 8/23/2023 due to an increase in the total return index.
CardioComm Solutions, Inc. (EKG.V) was upgraded to D from D- on 8/23/2023 due to an increase in the total return index.
D
Sell
8/8/2023Downgrade
CardioComm Solutions, Inc. (EKG.V) was downgraded to D- from D on 8/8/2023 due to a substantial decline in the valuation index, growth index and total return index.
CardioComm Solutions, Inc. (EKG.V) was downgraded to D- from D on 8/8/2023 due to a substantial decline in the valuation index, growth index and total return index.
D
Sell
6/17/2022Downgrade
CardioComm Solutions, Inc. (EKG.V) was downgraded to D from D+ on 6/17/2022 due to a noticeable decline in the volatility index and total return index.
CardioComm Solutions, Inc. (EKG.V) was downgraded to D from D+ on 6/17/2022 due to a noticeable decline in the volatility index and total return index.
D
Sell
6/2/2022Upgraded
CardioComm Solutions, Inc. (EKG.V) was upgraded to D+ from D on 6/2/2022 due to a major increase in the efficiency index, growth index and total return index. Total capital increased 320.91% from $11 to $46.3, EBIT increased 71.67% from $18 to $30.9, and total revenue increased 21.15% from $214.2 to $259.5.
CardioComm Solutions, Inc. (EKG.V) was upgraded to D+ from D on 6/2/2022 due to a major increase in the efficiency index, growth index and total return index. Total capital increased 320.91% from $11 to $46.3, EBIT increased 71.67% from $18 to $30.9, and total revenue increased 21.15% from $214.2 to $259.5.
D
Sell
5/4/2022Upgraded
CardioComm Solutions, Inc. (EKG.V) was upgraded to D from D- on 5/4/2022 due to a substantial increase in the valuation index, growth index and solvency index. Earnings per share increased from -$0.0003 to $0.0012, operating cash flow increased 298% from -$25 to $49.5, and EBIT increased 154.71% from -$32.9 to $18.
CardioComm Solutions, Inc. (EKG.V) was upgraded to D from D- on 5/4/2022 due to a substantial increase in the valuation index, growth index and solvency index. Earnings per share increased from -$0.0003 to $0.0012, operating cash flow increased 298% from -$25 to $49.5, and EBIT increased 154.71% from -$32.9 to $18.
D
Sell
4/20/2022Downgrade
CardioComm Solutions, Inc. (EKG.V) was downgraded to D- from D on 4/20/2022 due to a decline in the total return index.
CardioComm Solutions, Inc. (EKG.V) was downgraded to D- from D on 4/20/2022 due to a decline in the total return index.
D
Sell
11/9/2021Upgraded
CardioComm Solutions, Inc. (EKG.V) was upgraded to D from E+ on 11/09/2021.
CardioComm Solutions, Inc. (EKG.V) was upgraded to D from E+ on 11/09/2021.
E
Sell
11/8/2021Downgrade
CardioComm Solutions, Inc. (EKG.V) was downgraded to E+ from D on 11/8/2021 due to a noticeable decline in the total return index and volatility index.
CardioComm Solutions, Inc. (EKG.V) was downgraded to E+ from D on 11/8/2021 due to a noticeable decline in the total return index and volatility index.
D
Sell
9/1/2021Upgraded
CardioComm Solutions, Inc. (EKG.V) was upgraded to D from D- on 9/1/2021 due to a major increase in the growth index, total return index and volatility index. Operating cash flow increased 33.69% from -$84.9 to -$56.3, and total revenue increased 17.56% from $106.5 to $125.2.
CardioComm Solutions, Inc. (EKG.V) was upgraded to D from D- on 9/1/2021 due to a major increase in the growth index, total return index and volatility index. Operating cash flow increased 33.69% from -$84.9 to -$56.3, and total revenue increased 17.56% from $106.5 to $125.2.
D
Sell
8/23/2021Downgrade
CardioComm Solutions, Inc. (EKG.V) was downgraded to D- from D on 8/23/2021 due to a large decline in the growth index, solvency index and total return index. EBIT declined 498.4% from $12.5 to -$49.8, earnings per share declined from $0.0003 to -$0.0003, and operating cash flow declined 159.63% from -$32.7 to -$84.9.
CardioComm Solutions, Inc. (EKG.V) was downgraded to D- from D on 8/23/2021 due to a large decline in the growth index, solvency index and total return index. EBIT declined 498.4% from $12.5 to -$49.8, earnings per share declined from $0.0003 to -$0.0003, and operating cash flow declined 159.63% from -$32.7 to -$84.9.
D
Sell
4/19/2021Downgrade
CardioComm Solutions, Inc. (EKG.V) was downgraded to D from D+ on 4/19/2021 due to a decline in the total return index.
CardioComm Solutions, Inc. (EKG.V) was downgraded to D from D+ on 4/19/2021 due to a decline in the total return index.
D
Sell
3/16/2021Upgraded
CardioComm Solutions, Inc. (EKG.V) was upgraded to D+ from D on 3/16/2021 due to an increase in the total return index and valuation index.
CardioComm Solutions, Inc. (EKG.V) was upgraded to D+ from D on 3/16/2021 due to an increase in the total return index and valuation index.
D
Sell
3/1/2021Downgrade
CardioComm Solutions, Inc. (EKG.V) was downgraded to D from D+ on 3/1/2021 due to a decline in the total return index.
CardioComm Solutions, Inc. (EKG.V) was downgraded to D from D+ on 3/1/2021 due to a decline in the total return index.
D
Sell
2/12/2021Upgraded
CardioComm Solutions, Inc. (EKG.V) was upgraded to D+ from D on 2/12/2021 due to a significant increase in the total return index and volatility index.
CardioComm Solutions, Inc. (EKG.V) was upgraded to D+ from D on 2/12/2021 due to a significant increase in the total return index and volatility index.
D
Sell
12/15/2020Upgraded
CardioComm Solutions, Inc. (EKG.V) was upgraded to D from D- on 12/15/2020 due to an increase in the volatility index and total return index.
CardioComm Solutions, Inc. (EKG.V) was upgraded to D from D- on 12/15/2020 due to an increase in the volatility index and total return index.
D
Sell
11/30/2020Downgrade
CardioComm Solutions, Inc. (EKG.V) was downgraded to D- from D on 11/30/2020 due to a decline in the total return index, growth index and solvency index. Operating cash flow declined 62.01% from $60.8 to $23.1, and the quick ratio declined from 0.21 to 0.2.
CardioComm Solutions, Inc. (EKG.V) was downgraded to D- from D on 11/30/2020 due to a decline in the total return index, growth index and solvency index. Operating cash flow declined 62.01% from $60.8 to $23.1, and the quick ratio declined from 0.21 to 0.2.
D
Sell
9/1/2020Upgraded
CardioComm Solutions, Inc. (EKG.V) was upgraded to D from D- on 9/1/2020 due to a noticeable increase in the solvency index, growth index and total return index. Operating cash flow increased 466.27% from -$16.6 to $60.8, EBIT increased 87.19% from -$32 to -$4.1, and earnings per share increased from -$0.0004 to -$0.0002.
CardioComm Solutions, Inc. (EKG.V) was upgraded to D from D- on 9/1/2020 due to a noticeable increase in the solvency index, growth index and total return index. Operating cash flow increased 466.27% from -$16.6 to $60.8, EBIT increased 87.19% from -$32 to -$4.1, and earnings per share increased from -$0.0004 to -$0.0002.
D
Sell
8/24/2020Downgrade
CardioComm Solutions, Inc. (EKG.V) was downgraded to D- from D on 8/24/2020 due to a decline in the volatility index, total return index and solvency index.
CardioComm Solutions, Inc. (EKG.V) was downgraded to D- from D on 8/24/2020 due to a decline in the volatility index, total return index and solvency index.
D
Sell
6/23/2020Upgraded
CardioComm Solutions, Inc. (EKG.V) was upgraded to D from D- on 6/23/2020 due to a noticeable increase in the volatility index, total return index and valuation index.
CardioComm Solutions, Inc. (EKG.V) was upgraded to D from D- on 6/23/2020 due to a noticeable increase in the volatility index, total return index and valuation index.
D
Sell
6/3/2020Downgrade
CardioComm Solutions, Inc. (EKG.V) was downgraded to D- from D on 6/3/2020 due to a decline in the volatility index and total return index.
CardioComm Solutions, Inc. (EKG.V) was downgraded to D- from D on 6/3/2020 due to a decline in the volatility index and total return index.
D
Sell
5/1/2020Upgraded
CardioComm Solutions, Inc. (EKG.V) was upgraded to D from D- on 5/1/2020 due to an increase in the volatility index and growth index.
CardioComm Solutions, Inc. (EKG.V) was upgraded to D from D- on 5/1/2020 due to an increase in the volatility index and growth index.
D
Sell
11/29/2019Downgrade
CardioComm Solutions, Inc. (EKG.V) was downgraded to D- from D on 11/29/2019 due to a noticeable decline in the total return index, volatility index and growth index.
CardioComm Solutions, Inc. (EKG.V) was downgraded to D- from D on 11/29/2019 due to a noticeable decline in the total return index, volatility index and growth index.
D
Sell
8/30/2019Upgraded
CardioComm Solutions, Inc. (EKG.V) was upgraded to D from D- on 8/30/2019 due to a large increase in the growth index and valuation index. Operating cash flow increased 55.78% from -$50.2 to -$22.2, and earnings per share increased from -$0.0008 to -$0.0007.
CardioComm Solutions, Inc. (EKG.V) was upgraded to D from D- on 8/30/2019 due to a large increase in the growth index and valuation index. Operating cash flow increased 55.78% from -$50.2 to -$22.2, and earnings per share increased from -$0.0008 to -$0.0007.
D
Sell
5/2/2019Downgrade
CardioComm Solutions, Inc. (EKG.V) was downgraded to D- from D on 5/2/2019 due to a large decline in the growth index and efficiency index. EBIT declined 182.5% from -$48 to -$135.6, net income declined 142.11% from -$70.3 to -$170.2, and earnings per share declined from -$0.0005 to -$0.0012.
CardioComm Solutions, Inc. (EKG.V) was downgraded to D- from D on 5/2/2019 due to a large decline in the growth index and efficiency index. EBIT declined 182.5% from -$48 to -$135.6, net income declined 142.11% from -$70.3 to -$170.2, and earnings per share declined from -$0.0005 to -$0.0012.
D
Sell
2/20/2019Upgraded
CardioComm Solutions, Inc. (EKG.V) was upgraded to D from D- on 2/20/2019 due to an increase in the volatility index and total return index.
CardioComm Solutions, Inc. (EKG.V) was upgraded to D from D- on 2/20/2019 due to an increase in the volatility index and total return index.
D
Sell
12/17/2018Downgrade
CardioComm Solutions, Inc. (EKG.V) was downgraded to D- from D on 12/17/2018 due to a large decline in the total return index and volatility index.
CardioComm Solutions, Inc. (EKG.V) was downgraded to D- from D on 12/17/2018 due to a large decline in the total return index and volatility index.
D
Sell
11/30/2018Upgraded
CardioComm Solutions, Inc. (EKG.V) was upgraded to D from D- on 11/30/2018 due to a noticeable increase in the growth index, efficiency index and total return index. EBIT increased 65.49% from -$139.1 to -$48, earnings per share increased from -$0.0011 to -$0.0005, and net income increased 52.11% from -$146.8 to -$70.3.
CardioComm Solutions, Inc. (EKG.V) was upgraded to D from D- on 11/30/2018 due to a noticeable increase in the growth index, efficiency index and total return index. EBIT increased 65.49% from -$139.1 to -$48, earnings per share increased from -$0.0011 to -$0.0005, and net income increased 52.11% from -$146.8 to -$70.3.
D
Sell
8/31/2018Downgrade
CardioComm Solutions, Inc. (EKG.V) was downgraded to D- from D on 8/31/2018 due to a significant decline in the growth index, efficiency index and solvency index. Earnings per share declined from -$0.0004 to -$0.0011, net income declined 161.21% from -$56.2 to -$146.8, and EBIT declined 156.64% from -$54.2 to -$139.1.
CardioComm Solutions, Inc. (EKG.V) was downgraded to D- from D on 8/31/2018 due to a significant decline in the growth index, efficiency index and solvency index. Earnings per share declined from -$0.0004 to -$0.0011, net income declined 161.21% from -$56.2 to -$146.8, and EBIT declined 156.64% from -$54.2 to -$139.1.
D
Sell
5/2/2018Downgrade
CardioComm Solutions, Inc. (EKG.V) was downgraded to D from D+ on 5/2/2018 due to a significant decline in the valuation index, volatility index and growth index. Operating cash flow declined 235.85% from -$37.1 to -$124.6.
CardioComm Solutions, Inc. (EKG.V) was downgraded to D from D+ on 5/2/2018 due to a significant decline in the valuation index, volatility index and growth index. Operating cash flow declined 235.85% from -$37.1 to -$124.6.
D
Sell
3/15/2018Downgrade
CardioComm Solutions, Inc. (EKG.V) was downgraded to D+ from C- on 3/15/2018 due to a decline in the total return index.
CardioComm Solutions, Inc. (EKG.V) was downgraded to D+ from C- on 3/15/2018 due to a decline in the total return index.
C
Hold
2/28/2018Upgraded
CardioComm Solutions, Inc. (EKG.V) was upgraded to C- from D+ on 2/28/2018 due to an increase in the volatility index.
CardioComm Solutions, Inc. (EKG.V) was upgraded to C- from D+ on 2/28/2018 due to an increase in the volatility index.
D
Sell
12/26/2017Downgrade
CardioComm Solutions, Inc. (EKG.V) was downgraded to D+ from C- on 12/26/2017 due to a decline in the volatility index and total return index.
CardioComm Solutions, Inc. (EKG.V) was downgraded to D+ from C- on 12/26/2017 due to a decline in the volatility index and total return index.
C
Hold
12/8/2017Upgraded
CardioComm Solutions, Inc. (EKG.V) was upgraded to C- from D+ on 12/8/2017 due to an increase in the volatility index.
CardioComm Solutions, Inc. (EKG.V) was upgraded to C- from D+ on 12/8/2017 due to an increase in the volatility index.
D
Sell
11/30/2017Upgraded
CardioComm Solutions, Inc. (EKG.V) was upgraded to D+ from D on 11/30/2017 due to a significant increase in the valuation index, growth index and solvency index. Earnings per share increased from -$0.0001 to $0, the quick ratio increased from 1.04 to 1.08, and debt to equity declined from 1.35 to 1.34.
CardioComm Solutions, Inc. (EKG.V) was upgraded to D+ from D on 11/30/2017 due to a significant increase in the valuation index, growth index and solvency index. Earnings per share increased from -$0.0001 to $0, the quick ratio increased from 1.04 to 1.08, and debt to equity declined from 1.35 to 1.34.
D
Sell
10/5/2017Downgrade
CardioComm Solutions, Inc. (EKG.V) was downgraded to D from D+ on 10/5/2017 due to a decline in the volatility index, total return index and efficiency index.
CardioComm Solutions, Inc. (EKG.V) was downgraded to D from D+ on 10/5/2017 due to a decline in the volatility index, total return index and efficiency index.
D
Sell
9/7/2017Downgrade
CardioComm Solutions, Inc. (EKG.V) was downgraded to D+ from C- on 9/7/2017 due to a substantial decline in the total return index.
CardioComm Solutions, Inc. (EKG.V) was downgraded to D+ from C- on 9/7/2017 due to a substantial decline in the total return index.
C
Hold
8/31/2017Downgrade
CardioComm Solutions, Inc. (EKG.V) was downgraded to C- from C on 8/31/2017 due to a major decline in the efficiency index, growth index and volatility index. Earnings per share declined from $0.0001 to -$0.0001, and net income declined 154.91% from $17.3 to -$9.5.
CardioComm Solutions, Inc. (EKG.V) was downgraded to C- from C on 8/31/2017 due to a major decline in the efficiency index, growth index and volatility index. Earnings per share declined from $0.0001 to -$0.0001, and net income declined 154.91% from $17.3 to -$9.5.
C
Hold
8/14/2017Upgraded
CardioComm Solutions, Inc. (EKG.V) was upgraded to C from C- on 8/14/2017 due to an increase in the total return index and volatility index.
CardioComm Solutions, Inc. (EKG.V) was upgraded to C from C- on 8/14/2017 due to an increase in the total return index and volatility index.
C
Hold
6/5/2017Upgraded
Cardiocomm Solutions Inc. (EKG.V) was upgraded to C- from D+ on 6/5/2017 due to a major increase in the growth index, total return index and efficiency index. Net income increased 1,541.67% from -$1.2 to $17.3, EBIT increased 950% from -$1.8 to $15.3, and total revenue increased 24.65% from $285.6 to $356.
Cardiocomm Solutions Inc. (EKG.V) was upgraded to C- from D+ on 6/5/2017 due to a major increase in the growth index, total return index and efficiency index. Net income increased 1,541.67% from -$1.2 to $17.3, EBIT increased 950% from -$1.8 to $15.3, and total revenue increased 24.65% from $285.6 to $356.
D
Sell
5/17/2017Upgraded
Cardiocomm Solutions Inc. (EKG.V) was upgraded to D+ from D on 5/17/2017 due to a significant increase in the efficiency index, total return index and volatility index. Total capital increased 64.7% from $286.7 to $472.2.
Cardiocomm Solutions Inc. (EKG.V) was upgraded to D+ from D on 5/17/2017 due to a significant increase in the efficiency index, total return index and volatility index. Total capital increased 64.7% from $286.7 to $472.2.
D
Sell
11/16/2016Upgraded
Cardiocomm Solutions Inc. (EKG.V) was upgraded to D from D- on 11/16/2016 due to an increase in the total return index, efficiency index and solvency index. Net income increased 170.76% from -$17.1 to $12.1, total capital increased 55.39% from $184.5 to $286.7, and debt to equity declined from -1.34 to -1.67.
Cardiocomm Solutions Inc. (EKG.V) was upgraded to D from D- on 11/16/2016 due to an increase in the total return index, efficiency index and solvency index. Net income increased 170.76% from -$17.1 to $12.1, total capital increased 55.39% from $184.5 to $286.7, and debt to equity declined from -1.34 to -1.67.
D
Sell
5/13/2016Downgrade
Cardiocomm Solutions Inc. (EKG.V) was downgraded to D- from D+ on 5/13/2016 due to a significant decline in the efficiency index.
Cardiocomm Solutions Inc. (EKG.V) was downgraded to D- from D+ on 5/13/2016 due to a significant decline in the efficiency index.
D
Sell
5/2/2016Upgraded
Cardiocomm Solutions Inc. (EKG.V) was upgraded to D+ from D- on 5/2/2016 due to a significant increase in the efficiency index, growth index and total return index. Operating cash flow increased 232.2% from $5.9 to $19.6, earnings per share increased from -$0.0013 to -$0.001, and EBIT increased 20.84% from -$151.6 to -$120.
Cardiocomm Solutions Inc. (EKG.V) was upgraded to D+ from D- on 5/2/2016 due to a significant increase in the efficiency index, growth index and total return index. Operating cash flow increased 232.2% from $5.9 to $19.6, earnings per share increased from -$0.0013 to -$0.001, and EBIT increased 20.84% from -$151.6 to -$120.
D
Sell
3/11/2016Downgrade
Cardiocomm Solutions Inc. (EKG.V) was downgraded to D- from D on 3/11/2016 due to a major decline in the volatility index, total return index and solvency index. Debt to equity increased from -1.88 to -1.86.
Cardiocomm Solutions Inc. (EKG.V) was downgraded to D- from D on 3/11/2016 due to a major decline in the volatility index, total return index and solvency index. Debt to equity increased from -1.88 to -1.86.
D
Sell
6/2/2015Downgrade
Cardiocomm Solutions Inc. (EKG.V) was downgraded to D from D+ on 6/2/2015 due to a noticeable decline in the growth index, solvency index and volatility index. Operating cash flow declined 170.84% from $164.6 to -$116.6, earnings per share declined from -$0.0005 to -$0.0003, and debt to equity increased from -1.71 to -2.04.
Cardiocomm Solutions Inc. (EKG.V) was downgraded to D from D+ on 6/2/2015 due to a noticeable decline in the growth index, solvency index and volatility index. Operating cash flow declined 170.84% from $164.6 to -$116.6, earnings per share declined from -$0.0005 to -$0.0003, and debt to equity increased from -1.71 to -2.04.
D
Sell
5/15/2015Downgrade
Cardiocomm Solutions Inc. (EKG.V) was downgraded to D+ from C on 5/15/2015 due to a significant decline in the efficiency index and valuation index.
Cardiocomm Solutions Inc. (EKG.V) was downgraded to D+ from C on 5/15/2015 due to a significant decline in the efficiency index and valuation index.
C
Hold
5/1/2015Upgraded
Cardiocomm Solutions Inc. (EKG.V) was upgraded to C from D on 5/1/2015 due to a significant increase in the efficiency index, growth index and solvency index. Total revenue increased 217.8% from $150 to $476.7, and debt to equity declined from -1.78 to -0.03.
Cardiocomm Solutions Inc. (EKG.V) was upgraded to C from D on 5/1/2015 due to a significant increase in the efficiency index, growth index and solvency index. Total revenue increased 217.8% from $150 to $476.7, and debt to equity declined from -1.78 to -0.03.
D
Sell
10/7/2014Downgrade
Cardiocomm Solutions Inc. (EKG.V) was downgraded to D from D+ on 10/7/2014 due to a substantial decline in the volatility index and total return index.
Cardiocomm Solutions Inc. (EKG.V) was downgraded to D from D+ on 10/7/2014 due to a substantial decline in the volatility index and total return index.
D
Sell
9/4/2014Downgrade
Cardiocomm Solutions Inc. (EKG.V) was downgraded to D+ from C- on 9/4/2014 due to a significant decline in the growth index, total return index and volatility index. Total revenue declined 43.11% from $464.4 to $264.2.
Cardiocomm Solutions Inc. (EKG.V) was downgraded to D+ from C- on 9/4/2014 due to a significant decline in the growth index, total return index and volatility index. Total revenue declined 43.11% from $464.4 to $264.2.
C
Hold
6/4/2014Upgraded
Cardiocomm Solutions Inc. (EKG.V) was upgraded to C- from D+ on 6/4/2014 due to a substantial increase in the growth index and valuation index. Total revenue increased 275.73% from $123.6 to $464.4.
Cardiocomm Solutions Inc. (EKG.V) was upgraded to C- from D+ on 6/4/2014 due to a substantial increase in the growth index and valuation index. Total revenue increased 275.73% from $123.6 to $464.4.
